Heat-shock protein-peptide complex-96 for the treatment of cancer.
about
Vitespen: a preclinical and clinical review.Efficient cross-priming of antiviral CD8+ T cells by antigen donor cells is GRP94 independentAdvances in Immunotherapy for Glioblastoma Multiforme.Antigen-specific versus antigen-nonspecific immunotherapeutic approaches for human melanoma: the need for integration for optimal efficacy?Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications.
P2860
Heat-shock protein-peptide complex-96 for the treatment of cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Heat-shock protein-peptide complex-96 for the treatment of cancer.
@en
type
label
Heat-shock protein-peptide complex-96 for the treatment of cancer.
@en
prefLabel
Heat-shock protein-peptide complex-96 for the treatment of cancer.
@en
P2860
P1476
Heat-shock protein-peptide complex-96 for the treatment of cancer.
@en
P2093
Robert J Amato
P2860
P304
P356
10.1517/14712598.7.8.1267
P407
P577
2007-08-01T00:00:00Z